Skip to content

A Study of Survivorship Service Capacities Among Health Care Agencies in New York City

A Study of Survivorship Service Capacities Among Health Care Agencies in New York City

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00578162
Enrollment
Unknown
Registered
2007-12-21
Start date
2005-04-30
Completion date
2009-04-30
Last updated
2012-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All Cancers

Keywords

Cancer, Survivors

Brief summary

To describe the range of services available to cancer survivors in the NYC area. To determine organizations' need for assistance to enhance services for survivors.

Detailed description

To describe the range of services available to cancer survivors in the NYC area. To determine organizations' need for assistance to enhance services for survivors.

Interventions

BEHAVIORALwe will screen potential agencies using our CALL SCRIPT and our AGENCY SCREENER

A cancer care facility or 'agency' is the study's unit of analysis. Data about participating agencies will be collected by electronic survey. Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory

Sponsors

NYS DEPT HEALTH CANCER SVC PRO
CollaboratorUNKNOWN
Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* To be eligible to participate in the study, an agency must: 1. Be a current provider of either: * General health services (GHS), such as primary care, health education and wellness, mental health services, home health care, palliative care, or cancer screening and diagnosis; * Cancer-specific medical treatments (CMT), such as cancer surgery, radiation, chemotherapy, hormonal therapy; experimental therapies; cancer pain and symptom management; rehabilitation services; post-treatment monitoring and surveillance; or prophylactic treatments, such as chemoprevention; or * Any type of specialized 'post-cancer' or 'after-cancer' medical care or support services (SMC) (i.e., psychotherapeutic, relationship and family, psycho-educational,wellness and quality of life) 2. Be located within the five boroughs of New York City 3. Have been serving cancer patients for 12 months or longer, and 4. Be willing and able to identify an English-speaking representative, 21 years of age or older as its designated key informant.

Exclusion criteria

* We will limit this study to provider agencies such as hospitals, diagnostic centers, clinics, health and human service agencies, and grassroots community organizations and public service settings that offer programs for cancer survivors. Independent practitioners or private practice settings will not be surveyed. Our survey questions are intended for major health services organizations and are not appropriate for private practices settings. We will use our screening questionnaire to determine where or not a given agency should be included or excluded from the study AGENCY SCREENER.

Design outcomes

Primary

MeasureTime frame
To determine agencies' need for assistance to enhance services for survivors.2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026